Patterns of treatment in men with intermediate-, high-, and very high-risk prostate cancer according to their modelled life expectancy

被引：0
|
作者：
Irenaeus, S. [1 ]
Garmo, H. [2 ]
Gedeborg, R. [2 ]
Robinson, D. [3 ]
Stattin, P. [2 ]
Beckmann, K. [4 ]
机构：
[1] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden
[2] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
[3] Highland Hosp, Dept Urol, Eksjo, Sweden
[4] Univ South Australia, Canc Epidemiol & Populat Hlth Res Grp, Adelaide, SA, Australia
来源：
EUROPEAN UROLOGY | 2024年 / 85卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
A0424
引用
收藏
页码：S1265 / S1266
页数：2
相关论文
共 50 条
  • [1] Life Expectancy and Treatment Choice for Men with High-risk Prostate Cancer
    Daskivich, Timothy J.
    EUROPEAN UROLOGY, 2015, 68 (01) : 59 - 60
  • [2] Unification of favourable intermediate-, unfavourable intermediate-, and very high-risk stratification criteria for prostate cancer
    Zumsteg, Zachary S.
    Zelefsky, Michael J.
    Woo, Kaitlin M.
    Spratt, Daniel E.
    Kollmeier, Marisa A.
    McBride, Sean
    Pei, Xin
    Sandler, Howard M.
    Zhang, Zhigang
    BJU INTERNATIONAL, 2017, 120 (5B) : E87 - E95
  • [3] Localized intermediate- to high-risk prostate cancer
    Tritschler, S.
    Ganswindt, U.
    Stief, C. G.
    UROLOGE, 2016, 55 (03): : 318 - +
  • [4] A Pharmacodynamic Study of Rapamycin in Men with Intermediate- to High-Risk Localized Prostate Cancer
    Armstrong, Andrew J.
    Netto, George J.
    Rudek, Michelle A.
    Halabi, Susan
    Wood, David P.
    Creel, Patricia A.
    Mundy, Kelly
    Davis, S. Lindsay
    Wang, Ting
    Albadine, Roula
    Schultz, Luciana
    Partin, Alan W.
    Jimeno, Antonio
    Fedor, Helen
    Febbo, Phillip G.
    George, Daniel J.
    Gurganus, Robin
    De Marzo, Angelo M.
    Carducci, Michael A.
    CLINICAL CANCER RESEARCH, 2010, 16 (11) : 3057 - 3066
  • [5] Focal therapy in intermediate- and high-risk prostate cancer
    Huebner, Nicolai A.
    Korn, Stephan
    Rajwa, Pawel
    Shariat, Shahrokh F.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2023, 16 (04) : 247 - 250
  • [6] Focal therapy in intermediate- and high-risk prostate cancer
    Nicolai A. Huebner
    Stephan Korn
    Pawel Rajwa
    Shahrokh F. Shariat
    memo - Magazine of European Medical Oncology, 2023, 16 : 247 - 250
  • [7] Racial Disparities in the Management of African American Men With Intermediate- to High-Risk Prostate Cancer
    Mahal, B. A.
    Aizer, A. A.
    Ziehr, D. R.
    Hyatt, A. S.
    Sammon, J. D.
    Schmid, M.
    Choueiri, T. K.
    Hoffman, K. E.
    Hu, J. C.
    Sweeney, C. J.
    Beard, C. J.
    D'Amico, A. V.
    Martin, N. E.
    Kim, S. P.
    Trinh, Q.
    Nguyen, P. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S446 - S446
  • [8] Molecular correlates of intermediate- and high-risk localized prostate cancer
    Ye, Huihui
    Sowalsky, Adam G.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (08) : 368 - 374
  • [9] Whole Pelvic Radiation Therapy Versus Prostate Only in Patients With Intermediate-, High-, and Very High-Risk Prostate Cancer According NCCN Criteria Treated With Radical Intention: Recap Data Base
    Munoz Garcia, J.
    Cabeza Rodriguez, M. A.
    Jove i Teixido, J.
    Lopez Torrecilla, J.
    Hervas Moron, A.
    Henriquez Lopez, I.
    Casana Giner, M.
    Gonzalez San Segundo, C.
    Mengual Cloquell, J. L.
    Rios Kavadoy, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S361 - S361
  • [10] Thermal Partial Prostate Ablation for Intermediate- and High-risk Prostate Cancer: Con
    Gaffney, Christopher D.
    Ehdaie, Behfar
    EUROPEAN UROLOGY FOCUS, 2023, 9 (04): : 660 - 661
12345